New Therapy to Stop Mesothelioma Tumor Growth

New Therapy to Stop Mesothelioma Tumor Growth

Carbon-ion beam irradiation with cisplatin may stop the growth of malignant pleural mesothelioma. Researchers at one of the world’s most experienced carbon ion therapy centers in Chiba, Japan shared that conclusion in a new article in the American Journal of Cancer Research. New Treatment Strategy Carbon-ion beam irradiation is a new treatment strategy for different cancer types. It has been used to treat cancer in patients for almost 30 years. It involves using a particle accelerator to pummel a tumor with DNA-damaging carbon ions. Unlike conventional radiation, carbon ion therapy carries a lower risk of damaging healthy surrounding tissues since most of the energy is scattered as soon as the particles hit the cancer cells. This could be especially useful … Continue reading New Therapy to Stop Mesothelioma Tumor Growth »

Promising New Second-Line Treatment for Mesothelioma

Promising New Second-Line Treatment for Mesothelioma

Tislelizumab combined with anlotinib may be a promising new second-line treatment for malignant pleural mesothelioma. A mesothelioma patient in China was successfully treated with these drugs in 2021. The patient has survived for 10 months on this treatment. First-Line Treatments Malignant pleural mesothelioma develops from the thin layer of tissue that covers the lungs and chest wall. It is caused by exposure to asbestos. A healthy pleura is thin and flexible and expands to accommodate the lungs during respiration. In a person with mesothelioma, this membrane becomes thick and stiff, constricting the lungs and causing shortness of breath. First-line treatment for mesothelioma may be chemotherapy, radiation, or therapy. Depending on the health of the patient, more than one treatment might … Continue reading Promising New Second-Line Treatment for Mesothelioma »

Body Radiation Therapy for Mesothelioma

Body Radiation Therapy for Mesothelioma

Stereotactic body radiation therapy may be a safe treatment option for patients with malignant pleural mesothelioma. This is the finding of a team of researchers from Memorial Sloan Kettering Cancer Center in New York. Stereotactic Body Radiation Therapy Malignant pleural mesothelioma is a difficult cancer to treat. It develops from the thin layer of tissue that covers the lungs and chest wall. Signs and symptoms may include shortness of breath due to fluid around the lung, chest pain, cough, and fatigue. This cancer is caused by exposure to asbestos. It can often take around 40 years for pleural mesothelioma to begin. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Conventional treatment may include surgery, radiation … Continue reading Body Radiation Therapy for Mesothelioma »

Improving Survival in Malignant Pleural Mesothelioma

Improving Survival in Malignant Pleural Mesothelioma

Surgery to remove cancer tissue can lead to improved survival for epithelioid malignant pleural mesothelioma (MPM). Patients with sarcomatoid or biphasic malignant pleural mesothelioma did not have the same results. This is the finding of a study that looked at patient data from the National Cancer Database. Worst Prognosis with Standard Therapies MPM is an aggressive cancer that develops in the lining of the lungs. It is caused by exposure to asbestos and is difficult to treat. There are three cell types for this type of cancer: epithelioid, sarcomatoid, and biphasic. About half of malignant mesotheliomas are epithelioid. This type tends to have better treatment outcomes. About 10% of mesotheliomas are sarcomatoid. This type generally has the worst prognosis with … Continue reading Improving Survival in Malignant Pleural Mesothelioma »

Immune Checkpoint Inhibitors to Treat Mesothelioma

Immune Checkpoint Inhibitors to Treat Mesothelioma

A new study supports the use of immune checkpoint inhibitors to treat malignant pleural mesothelioma. The study authors caution that immune checkpoint inhibitors should be used carefully because they can be an expensive treatment. Immunotherapy for Mesothelioma Mesothelioma is a rare type of cancer that is caused by exposure to asbestos. It develops from cells of the mesothelium, the lining that covers many of the internal organs of the body. There are approximately 2,000 cases of mesothelioma diagnosed in the United States every year. Since mesothelioma is so rare, standard treatment options are limited. Standard therapies include chemotherapy, radiation, and surgery. If more than one of these therapies is used, it may be called multimodal therapy. Immunotherapy has emerged in … Continue reading Immune Checkpoint Inhibitors to Treat Mesothelioma »

Stronger Mesothelioma Clinical Trials for Better Results

Stronger Mesothelioma Clinical Trials for Better Results

A commentary by an international team of researchers raises some concerns about how clinical cancer trials are conducted. The authors of the commentary hail from Israel, Italy, Ireland, and the United States. They claim that there is a need for better balance between the cost of new cancer drugs and their actual benefit to patients. The authors came to this conclusion after analyzing clinical trials for treatments for pleural mesothelioma. Gold Standard for Mesothelioma Treatments Mesothelioma is a rare form of cancer. It most often appears in older adults and is caused by exposure to asbestos. Asbestos is a toxic material that can be found in industrial and consumer products. Malignant pleural mesothelioma is a specific type of mesothelioma. It … Continue reading Stronger Mesothelioma Clinical Trials for Better Results »

New Combination Chemotherapy Drug for Mesothelioma

New Combination Chemotherapy Drug for Mesothelioma

A recent study has found that a new drug for mesothelioma chemotherapy could improve treatment outcomes. The new drug is called abemaciclib. It works by blocking cancer cells from multiplying within the body. This helps to stop tumors from growing and spreading. The researchers in this study used cell samples from mesothelioma patients to test the drug. Their study found that adding abemaciclib to the standard chemotherapy treatment helped to stop the growth of mesothelioma cancer cells. Common Treatment Options Mesothelioma is an extremely rare cancer caused by exposure to asbestos. It affects the membranes around organs like the lungs and abdominal cavity. It takes a long time for symptoms to appear. By then, the cancer has usually become difficult … Continue reading New Combination Chemotherapy Drug for Mesothelioma »

Immunotherapy as Effective Second-Line Treatment for Mesothelioma

Effective Second-Line Treatment for Mesothelioma

A study from Taiwan has identified an effective second-line treatment for malignant pleural mesothelioma. When a patient is diagnosed with mesothelioma and begins treatment, the first treatment is called the “first-line treatment.” If that treatment does not work or stops working, a “second-line treatment” is given to the patient. For mesothelioma, treatment usually consists of surgery, chemotherapy, and radiation. The exact treatment plan will depend on many factors. Doctors will consider the type of mesothelioma, the condition of the patient, and how much the cancer has spread. A common first-line treatment for mesothelioma patients is chemotherapy with drugs called pemetrexed and cisplatin. When this treatment works properly, it stops cancer cells from growing and multiplying. It is for patients whose … Continue reading Immunotherapy as Effective Second-Line Treatment for Mesothelioma »

New Mesothelioma Tool for Better Treatment and Prognosis

New Mesothelioma Tool for Better Treatment and Prognosis

Researchers from China have come up with a tool to check prognosis in mesothelioma patients depending on where the cancer is located. Mesothelioma develops in the lining that covers many of the internal organs in you body. It is caused by exposure to asbestos. There are different types of mesothelioma depending on where it develops. Pleural mesothelioma grows in the lining of your lungs and chest wall. Peritoneal mesothelioma grows in the lining of your abdomen. Mesothelioma can also occur in the testis or around the heart. The location where mesothelioma grows can have a big impact on diagnosis. It also affects how well you respond to treatment. When it takes longer to make an accurate diagnosis, the disease has … Continue reading New Mesothelioma Tool for Better Treatment and Prognosis »

Mesothelioma Breakthrough Can Spare the Diaphragm

Mesothelioma Breakthrough Can Spare the Diaphragm

A new study shows that surgery for malignant pleural mesothelioma can spare the diaphragm without reducing overall survival. This study was conducted by medical researchers from St. Bartholomew’s Hospital in the United Kingdom. Surgery for Malignant Pleural Mesothlioma Mesothelioma is a type of cancer caused by exposure to asbestos. It can take decades after asbestos exposure for the cancer to develop. It is an aggressive cancer and can be hard to treat. When the cancer grows in your lungs, it is called malignant pleural mesothelioma (MPM). Conventional treatment for MPM may include surgery, radiation therapy, and chemotherapy. Surgery is the most invasive treatment option and not every patient is eligible for surgery. If the patient is too ill or if … Continue reading Mesothelioma Breakthrough Can Spare the Diaphragm »

Get your free copy of
“Surviving Mesothelioma” Today!